Cartesian Therapeutics (RNAC) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

RNAC is expected to report earnings to fall 40.00% to -89 cents per share on May 09

Cartesian Therapeutics RNAC Stock Earnings Reports

Q1'24

Est.

$-0.90

Q4'23

Missed

by $1.47

Q3'23

Missed

by $1.28

Q2'23

Beat

by $0.01

Q1'23

Missed

by $4.11

The last earnings report on March 07 showed earnings per share of -150 cents, missing the estimate of -2 cents. With 53.68K shares outstanding, the current market capitalization sits at 298.93M.

View a ticker or compare two or three

Compare

RNAC

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For RNAC
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for RNAC (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of targeted immunotherapies and vaccines to treat and prevent diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

704 Quince Orchard Road

Phone

+1 617 923-1400

Employees

Web

https://www.cartesiantherapeutics.com